Michael H. Goldbaum, None; Christopher Bowd, None; Intae Lee, None; Madhusudhanan Balasubramanian, None; Felipe A. Medeiros, Alcon Laboratories Inc (F, C, R), Allergan Inc (C, R), Carl Zeiss Meditec Inc (F, R), Merck Inc (F), Pfizer Inc (F, C, R), Reichert Inc (R); Linda M. Zangwill, Carl Zeiss Meditec Inc (F), Heidelberg Engineering GmbH (F), Nidek (F), Optovue Inc (F), Topcon Medical Systems Inc (F); Christopher A. Girkin, None; Jeffrey M. Liebmann, Alcon Laboratories Inc (C), Allergan Inc (C), Carl Zeiss Meditec Inc (F), Dyopsis Corp (F, C), Heidelberg Engineering Inc (F), Merz Pharmaceuticals Inc (C), Optovue Inc (F), Quark Pharmaceuticals Inc (C), Topcon Medical Systems Inc (F, C); Pamela A. Sample, None; Robert N. Weinreb, Alcon Laboratories Inc (C), Bausch&Lomb (C), Carl Zeiss Meditec (F), Carl Zeiss Meditec Inc (C), Heidelberg Engineering GmbH (F), Merck Inc (C), Nidek (F), Novartis (F), Optovue (F), Optovue Inc (C), Pfizer Inc (C), Topcon Medical Systems (F)